Continuous subcutaneous insulin infusion during pregnancy

Kenneth J. Leveno, Stephen J. Fortunato, Philip Raskin, M. Lynne Williams, Peggy J. Whalley

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The development of battery-powered pumps for continuous subcutaneous insulin infusion added new dimensions to control of diabetes during pregnancy. In this report, we describe our experiences with 28 pregnant diabetic women offered participation in an insulin pump program. Fifteen (54%) accepted pump therapy and ten continued usage during their pregnancies. Excluding abortions, eight women continuing pump use are compared to 11 others who declined such theray and were treated with conventional methods. Although these two groups are small and not strictly comparable, the experiences now reported provide clinical insights into the application of this new technology during pregnancy. Women who successfully used insulin pumps were typically from the private sector and in better glucose control at study entry. The degree of control during pregnancy in women using pumps was not significantly different compared to conventional glucose control methods (mean glucose 120 mg/dl and 142 mg/dl, respectively). Similarly, several indices of pregnancy outcome including length of hospitalization, costs, and perinatal morbidity associated with diabetes were analyzed and no significant differences were observed. We conclude that insulin pumps are not acceptable to all pregnant diabetic women and that such therapy may not necessarily improve pregnancy outcome.

Original languageEnglish (US)
Pages (from-to)257-268
Number of pages12
JournalDiabetes Research and Clinical Practice
Volume4
Issue number4
DOIs
StatePublished - Apr 6 1988

Fingerprint

Subcutaneous Infusions
Insulin
Pregnancy
Pregnancy Outcome
Glucose
Pregnant Women
Private Sector
Hospitalization
Technology
Morbidity
Costs and Cost Analysis
Therapeutics

Keywords

  • Insulin pump
  • Pregnancy

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Continuous subcutaneous insulin infusion during pregnancy. / Leveno, Kenneth J.; Fortunato, Stephen J.; Raskin, Philip; Williams, M. Lynne; Whalley, Peggy J.

In: Diabetes Research and Clinical Practice, Vol. 4, No. 4, 06.04.1988, p. 257-268.

Research output: Contribution to journalArticle

@article{6805fdb1efbd480e90e8ab93a04d5f97,
title = "Continuous subcutaneous insulin infusion during pregnancy",
abstract = "The development of battery-powered pumps for continuous subcutaneous insulin infusion added new dimensions to control of diabetes during pregnancy. In this report, we describe our experiences with 28 pregnant diabetic women offered participation in an insulin pump program. Fifteen (54{\%}) accepted pump therapy and ten continued usage during their pregnancies. Excluding abortions, eight women continuing pump use are compared to 11 others who declined such theray and were treated with conventional methods. Although these two groups are small and not strictly comparable, the experiences now reported provide clinical insights into the application of this new technology during pregnancy. Women who successfully used insulin pumps were typically from the private sector and in better glucose control at study entry. The degree of control during pregnancy in women using pumps was not significantly different compared to conventional glucose control methods (mean glucose 120 mg/dl and 142 mg/dl, respectively). Similarly, several indices of pregnancy outcome including length of hospitalization, costs, and perinatal morbidity associated with diabetes were analyzed and no significant differences were observed. We conclude that insulin pumps are not acceptable to all pregnant diabetic women and that such therapy may not necessarily improve pregnancy outcome.",
keywords = "Insulin pump, Pregnancy",
author = "Leveno, {Kenneth J.} and Fortunato, {Stephen J.} and Philip Raskin and Williams, {M. Lynne} and Whalley, {Peggy J.}",
year = "1988",
month = "4",
day = "6",
doi = "10.1016/S0168-8227(88)80027-5",
language = "English (US)",
volume = "4",
pages = "257--268",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "4",

}

TY - JOUR

T1 - Continuous subcutaneous insulin infusion during pregnancy

AU - Leveno, Kenneth J.

AU - Fortunato, Stephen J.

AU - Raskin, Philip

AU - Williams, M. Lynne

AU - Whalley, Peggy J.

PY - 1988/4/6

Y1 - 1988/4/6

N2 - The development of battery-powered pumps for continuous subcutaneous insulin infusion added new dimensions to control of diabetes during pregnancy. In this report, we describe our experiences with 28 pregnant diabetic women offered participation in an insulin pump program. Fifteen (54%) accepted pump therapy and ten continued usage during their pregnancies. Excluding abortions, eight women continuing pump use are compared to 11 others who declined such theray and were treated with conventional methods. Although these two groups are small and not strictly comparable, the experiences now reported provide clinical insights into the application of this new technology during pregnancy. Women who successfully used insulin pumps were typically from the private sector and in better glucose control at study entry. The degree of control during pregnancy in women using pumps was not significantly different compared to conventional glucose control methods (mean glucose 120 mg/dl and 142 mg/dl, respectively). Similarly, several indices of pregnancy outcome including length of hospitalization, costs, and perinatal morbidity associated with diabetes were analyzed and no significant differences were observed. We conclude that insulin pumps are not acceptable to all pregnant diabetic women and that such therapy may not necessarily improve pregnancy outcome.

AB - The development of battery-powered pumps for continuous subcutaneous insulin infusion added new dimensions to control of diabetes during pregnancy. In this report, we describe our experiences with 28 pregnant diabetic women offered participation in an insulin pump program. Fifteen (54%) accepted pump therapy and ten continued usage during their pregnancies. Excluding abortions, eight women continuing pump use are compared to 11 others who declined such theray and were treated with conventional methods. Although these two groups are small and not strictly comparable, the experiences now reported provide clinical insights into the application of this new technology during pregnancy. Women who successfully used insulin pumps were typically from the private sector and in better glucose control at study entry. The degree of control during pregnancy in women using pumps was not significantly different compared to conventional glucose control methods (mean glucose 120 mg/dl and 142 mg/dl, respectively). Similarly, several indices of pregnancy outcome including length of hospitalization, costs, and perinatal morbidity associated with diabetes were analyzed and no significant differences were observed. We conclude that insulin pumps are not acceptable to all pregnant diabetic women and that such therapy may not necessarily improve pregnancy outcome.

KW - Insulin pump

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=0023902929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023902929&partnerID=8YFLogxK

U2 - 10.1016/S0168-8227(88)80027-5

DO - 10.1016/S0168-8227(88)80027-5

M3 - Article

C2 - 3286165

AN - SCOPUS:0023902929

VL - 4

SP - 257

EP - 268

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 4

ER -